Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study

Authors

  • Hayder Al-Momen

DOI:

https://doi.org/10.47723/kcmj.v13i1.130

Downloads

Published

2019-04-18

How to Cite

1.
Al-Momen H. Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study. Al-Kindy Col. Med. J [Internet]. 2019 Apr. 18 [cited 2024 Mar. 28];13(1):76-81. Available from: https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/130